Evaluating the Impact of Phosphatidylethanol Testing on Hospital Outcomes
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Evaluating the Impact of Phosphatidylethanol Testing on Hospital Outcomes

Evaluating the Impact of Phosphatidylethanol Testing on Hospital Outcomes

Abstract

Background: Alcohol dependence remains a significant global health issue, exacerbated by the coronavirus disease 2019 (COVID-19) pandemic. Phosphatidylethanol (PEth), a direct biomarker of recent alcohol consumption, offers improved specificity, sensitivity, and a longer detection window of 2 - 4 weeks compared to traditional biomarkers. This study evaluates the association between PEth testing and hospital outcomes in hospitalized patients by comparing outcomes among patients with positive PEth and negative PEth test results.

Read Article


Metadata